About
Kinase Inhibitor
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
1,370
By Phase
PHASE2: 4PHASE3: 2PHASE1: 2
By Status
COMPLETED: 4ACTIVE_NOT_RECRUITING: 3WITHDRAWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07071610Lead Sponsor
A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis
PHASE2Active, not recruiting
75 participants
Started: Mar 18, 2025 · Completed: Jul 31, 2025
NCT06277245Lead Sponsor
A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.
PHASE3Active, not recruiting
354 participants
Started: Feb 6, 2024 · Completed: Nov 30, 2025
NCT06276998Lead Sponsor
A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis
PHASE3Active, not recruiting
430 participants
Started: Dec 12, 2023 · Completed: Nov 20, 2026
NCT06553287Lead Sponsor
Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.
PHASE1Completed
28 participants
Started: Jul 12, 2023 · Completed: Jun 18, 2024
NCT06085521Lead Sponsor
A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis
PHASE2Completed
150 participants
Started: Jan 26, 2022 · Completed: Jun 14, 2023
Locations (1)
Headquarters
Hangzhou, China
Map
Loading map...